The companies ENSIS and MAHOU are collaborating in this consortium project focused on the research and development of fermented beverages capable of modulating the intestinal microbiota and improving the quality of life of people with metabolic osteoarthritis. These companies have subcontracted AINIA to carry out in vitro preclinical studies on gastrointestinal digestion, colonic fermentation, and the biological effects of the ingredients and products developed within the project. The project is funded by CDTI.